| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study
Sung Gu Kang, Eu Chang Hwang, Seung Il Jung, Ho Song Yu, Ho Seok Chung, Taek Won Kang, Dong Deuk Kwon, Jun Eul Hwang, Jun Seok Kim, Joon Hwa Noh, Jae Hyung You, Myung Ki Kim, Tae Hoon Oh, Ill Young Seo, Seung Baik, Chul-Sung Kim, Seok Ho Kang, Jun Cheon
Cancer Res Treat. 2016;48(4):1293-1301.   Published online March 23, 2016    DOI: https://doi.org/10.4143/crt.2016.021
                           Web of Science 8  Crossref 7
Conditional Survival and Associated Prognostic Factors in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Retrospective Study at a Single Institution
Minyong Kang, Hyung Suk Kim, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku
Cancer Res Treat. 2016;48(2):621-631.   Published online September 9, 2015    DOI: https://doi.org/10.4143/crt.2015.220
                        Supplementary         Web of Science 9  Crossref 9
CD10 Is Again Expressed at a Certain Stage during the Neoplastic Process of Bladder Transitional Cell Carcinomas
Tae Jung Jang
Cancer Res Treat. 2012;44(4):262-266.   Published online December 31, 2012    DOI: https://doi.org/10.4143/crt.2012.44.4.262
                           Crossref 2
Results of Additional BCG Therapy for Recurrent Transitional Cell Carcinoma after Complete Response to Initial BCG Therapy
H S Ha, C H Park, C I Kim
J Korean Cancer Assoc. 2000;32(2):367-373.
      
Usefulness of MIB1 Expression as a Prognostic Factor in Transitional Cell Carcinoma of Urinary Bladder
Han Kyeum Kim, Young Sik Kim, In Sun Kim
J Korean Cancer Assoc. 1995;27(3):459-468.
      
Methotrexate , Vinblastine , Doxorubicin and Cisplatin
Jin Soo Chung, Hyeon Hoe Kim, Chong Wook Lee
J Korean Cancer Assoc. 1994;26(4):618-626.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI